STATEMENTS OF CONSOLIDATED CASH FLOWS (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash Flows From Operating Activities:
Net income (loss)	$ (1,497,040)	$ (8,340,088)
Adjustments to reconcile net income to net cash provided by (used for) operating activities
Stock-based compensation expense	290,099	617,758
Amortization of intangible assets	0	98,304
Advertising expense paid with common stock	211,200	554,000
Common stock issued in connection with financing	51,010	0
Amortization of debt discount	954,024	1,704,907
Loss on the extinguishment of debt	1,226,489	0
Change in the fair value of derivatives	(2,694,220)	1,748,237
Depreciation	1,946	1,146
Changes in operating assets and liabilities
(Increase)/decrease in prepaid expenses	(35,170)	1,824,558
HST Receivable	(1,035)	26,954
Accrued interest	(52,538)	74,623
Loan payable related party	0	(15,158)
Accounts payable/loan payable related party	0	198,780
Accrued expense related party	42,726	442,951
Accounts payable and accrued expense	(584,859)	230,706
Net cash provided by (used for) operating activities	(2,087,367)	(832,322)
Cash Flows From Investing Activities:
Purchase of fixed assets	(6,232)	0
Net impact from sale of AMS building excluding mortgage payoff	539,376	0
Purchase of private company equity	(39,490)	0
Changes in intangible assets	0	95,681
Net cash provided by (used for) investing activities	493,654	95,681
Cash Flows From Financing Activities:
Proceeds from the sale of preferred stock	410,000	0
Proceeds from convertible loans, net of repayments	427,086	945,000
Proceeds from notes payable, net of repayment	238,560	(3,566)
Proceeds from the sale of common stock in private placements	291,064	0
Proceeds (repayment of related party loans), net	(255,001)	(15,158)
Net cash provided by (used for) financing activities	1,111,709	926,276
Effect of exchange rates on cash and cash equivalents	259,857	52,132
Net Increase (Decrease) In Cash	(482,004)	189,635
Cash At The Beginning Of The Period	334,969	1,547
Cash At The End Of The Period	112,822	243,314
Supplemental disclosure of cash flow information:
Cash paid for interest	0	14,744
Cash paid for income taxes	0	0
Supplemental disclosure of non-cash investing and financing activities:
Common stock issued as a financing expense on convertible notes	51,010	0
Common stock issued for advertising expense	211,200	554,000
Common stock issued related to investment in Great Northern Cannabis	0	2,478,422
Common stock issued to convert convertible notes and accrued interest into equity	$ 918,611	$ 306,750